Priority Health has chosen Arine, the medication intelligence company, as its partner in a value-based care endeavor that strives to optimize members' health outcomes.
Grand Rapids, Michigan — Wanting to identify the top medication management program for its members—encompassing medication therapy, reduced costs, and improved health outcomes—Priority Health in November chose Arine, the medication intelligence company, as its partner in this value-based care endeavor.
Arine’s artificial intelligence (AI) capabilities will enable the nonprofit health plan to continue providing optimal care to its members while also striving for top quality ratings for several CMS’ Part C and D Star measures. In particular, Arine’s AI has the ability to pinpoint safe and effective, individualized, medication regimens by examining clinical, socioeconomic, and behavioral data.
“Priority Health is committed to improving health outcomes for our members and reducing costs,” said Christina Barrington, vice president of pharmacy programs at Priority Health. “Through this partnership, our members will continue receiving the care they need, lower their prescription costs and receive personalized medication advice.”
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More